Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity
Source abstract
Abstract
Decellularized xenogeneic tissue represents an interesting material for heart valve tissue engineering. The prospect objective is removal of all viable cells while preserving extracellular matrix (ECM) integrity. The major concerns of all decellularization protocols remain ECM disruption, immunogenicity and thrombogenicity. Accordingly the aim of this study was visualization of ultrastructural ECM disruption and human immune response and thrombogenicity using different decellularization protocols of porcine heart valves. Porcine pulmonary leaflets were decellularized with four different protocols: sodium deoxycholate, sodium dedecylsulfate, trypsin/EDTA, and trypsin-detergent-nuclease. Then the tissues were processed for histology and two-photon laser scanning microscopy (LSM). For thrombogenicity and immunogenicity testing tissues were incubated with human blood. The histological examination revealed no remaining cells and no significant differences in the ECM histoarchitecture in any group. LSM detected significant ECM alterations in all groups except sodium deoxycholate group with an almost completely preserved ECM. There was no increased immunogenicity between fresh and decellularized tissue. Compared to GA-fixed tissue however significantly increased immune responses and thrombogenicity was observed in all protocols. From our experiment, sodium deoxycholate enables cell removal with almost complete preservation of ECM structures. And all of these four decellularization protocols affected human immunological response and increased thrombogenicity.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Cardiac and Coronary Surgery Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (21)
Show source-provided references
1. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves10.1016/j.jsb.2003.08.002 ↗
2. Ross operation with a tissue-engineered heart valve10.1016/S0003-4975(02)03881-X ↗
3. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves
4. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves10.1016/j.matbio.2004.03.005 ↗
5. Comparison of different decellularization procedures of porcine heart valves10.1177/039139880302600508 ↗
6. Two-photon microscopes and in vivo multiphoton tomographs — powerful diagnostic tools for tissue engineering and drug delivery10.1016/j.addr.2006.07.004 ↗
7. Fritze O, Schleicher M, Koenig K, Schenke-Layland K, Stock U, Harasztosi C. Facilitated Non-Invasive Visualization of Collagen and Elastin in Blood Vessels. Tissue Eng Part C Methods 2009 Oct 5 [Epub ahead of press].10.1089/ten.tec.2009.0309 ↗
8. High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution10.1117/1.1577349 ↗
9. Reduced thrombogenicity of nitinol stents – in vitro evaluation of different surface modifications and coatings10.1016/j.biomaterials.2005.06.004 ↗
10. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions10.1211/0022357021620 ↗
11. Activation of the complement system by different autologous transfusion devices: an in vitro study10.1046/j.1537-2995.2003.00311.x ↗
12. Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion10.1080/14017430310002185 ↗
13. Platelet responses and coagulation activation on polylactide and heparin-poly -caprolactone-l-lactide-coated polylactide stent struts10.1002/jbm.a.10154 ↗
14. Clinical application of tissue engineered human heart valves using autologous progenitor cells10.1161/CIRCULATIONAHA.105.001065 ↗
15. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the ross procedure10.1016/j.athoracsur.2007.04.072 ↗
16. Biomechanical characterization of decellularized and cross-linked bovine pericardium
17. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation10.1160/TH05-01-0025 ↗
18. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation
19. Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver10.1097/00007890-199911270-00005 ↗
20. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients10.1016/S1010-7940(03)00094-0 ↗
21. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue10.1016/j.biomaterials.2008.01.005 ↗